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Manganese-enhanced MRI depicts 
a reduction in brain responses to nociception 
upon mTOR inhibition in chronic pain rats
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Abstract 
Neuropathic pain induced by a nerve injury can lead to chronic pain. Recent studies have reported hyperactive neural 
activities in the nociceptive-related area of the brain as a result of chronic pain. Although cerebral activities associated 
with hyperalgesia and allodynia in chronic pain models are difficult to represent with functional imaging techniques, 
advances in manganese (Mn)-enhanced magnetic resonance imaging (MEMRI) could facilitate the visualization of 
the activation of pain-specific neural responses in the cerebral cortex. In order to investigate the alleviation of pain 
nociception by mammalian target of rapamycin (mTOR) modulation, we observed cerebrocortical excitability changes 
and compared regional  Mn2+ enhancement after mTOR inhibition. At day 7 after nerve injury, drugs were applied 
into the intracortical area, and drug (Vehicle, Torin1, and XL388) effects were compared within groups using MEMRI. 
Therein, signal intensities of the insular cortex (IC), primary somatosensory cortex of the hind limb region, motor cor-
tex 1/2, and anterior cingulate cortex regions were significantly reduced after application of mTOR inhibitors (Torin1 
and XL388). Furthermore, rostral-caudal analysis of the IC indicated that the rostral region of the IC was more strongly 
associated with pain perception than the caudal region. Our data suggest that MEMRI can depict pain-related signal 
changes in the brain and that mTOR inhibition is closely correlated with pain modulation in chronic pain rats.
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Introduction
Neuropathic pain arises from an initial injury, such as 
neuropathy caused by a lesion of or damage to the soma-
tosensory nervous system, that can lead to chronic pain 
[1]. While identifying brain abnormalities underlying 
chronic pain sensation could be a first step in clinical 
treatment, investigation of changes in cerebral neuronal 
activity is a challenge for functional imaging. Neverthe-
less, current manganese-enhanced magnetic resonance 
imaging (MEMRI) tools have provided a viable method 
for visualizing cortical responses after evoked and/
or spontaneous pain [2, 3]. The chemical properties of 
 Mn2+ resemble those of  Ca2+, and  Mn2+ acts as a par-
amagnetic neuronal tract tracer, as its transport uses 
voltage-gated  Ca2+ channels throughout the nervous sys-
tem [4–6]. Experimental hyperalgesia produces the up-
regulated neuronal activation of brain responses within 
pain-processing regions, including the anterior cingu-
late cortex (ACC), insular cortex (IC), and primary (SI) 
and secondary somatosensory cortices (SII) [7–9]. With 
MEMRI studies having been found useful in identifying 
pain pathways in the brain, various pain imaging studies 
have been performed in the spinal cord and brain [5, 6], 
allowing researchers to visualize nerve injury [10] and 
thermal [11] stimulus-induced abnormal brain activities. 
Similarly, our previous formalin-induced pain study also 
showed that MEMRI could be a good indicator of pain-
induced changes in the central nervous system (CNS).
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Mammalian target of rapamycin (mTOR), a serine-
threonine protein kinase, is known to regulate mRNA 
translation in the nervous system, and it plays impor-
tant roles in cell proliferation and differentiation [12]. 
Although the roles of the mTOR pathway in cancer 
research have been extensively studied, there has been 
no in-depth study on the role of mTOR signaling in pain 
research. Recent studies have reported that neuropathic 
pain is related to structural changes in the CNS after 
nerve injury, known as mTOR-mediated neuronal plas-
ticity [13–16]. The activation of mTOR regulates protein 
synthesis and influences a wide range of physiological 
and pathological states by phosphorylating downstream 
effectors [12, 17, 18]. In this study, the mTOR selective 
inhibitors, Torin1 [19, 20] and XL388 [21], were used to 
modulate mTOR regulator: each agent has highly potent 
and ATP-competitive mTOR inhibitory effects.
Here, we investigated changes in cerebrocortical 
excitability in nerve injury-induced chronic pain using 
MEMRI and compared noxious stimulation-dependent 
regional signal changes after application of the mTOR 
inhibitors using  Mn2+ enhancement in rats. In particular, 
we analyzed the distributions of  Mn2+ enhancement in 
the rostral and caudal parts of regions of interest (ROI) 
shown to be associated with different roles in pain per-
ception. These findings may contribute to the knowledge 
of hyperalgesia in the brain as the result of nerve injury-
induced chronic pain and may suggest potential thera-
peutic targets against mTOR in chronic pain.
Materials and methods
Animal preparation
Male Sprague–Dawley rats (n = 24, 250–300 g, Koatech, 
Pyeongtaek, Korea) were used in this study. All animal 
experiments were approved by the Institutional Animal 
Care and Use Committee (IACUC) of the Yonsei Uni-
versity Health System (protocol number 2016–0061). 
All experiments were performed in accordance with 
the IACUC guidelines and regulations. Animals were 
housed in plastic cages with soft bedding on a 12-h light/
dark cycle (light cycle: 08:00 ~ 20:00), at a constant tem-
perature (22 ± 2℃) and humidity (50 ± 10%). The experi-
mental procedures according to the time sequence are 
summarized in Fig.  1. Rats were anesthetized with an 
intraperitoneal (i.p.) injection of sodium pentobarbi-
tal (50  mg/kg). Deep anesthesia was verified by loss of 
nociception in response to a tail pinch stimulation. The 
surgical procedure for nerve injury was performed fol-
lowing the methods described in our previous report 
[22, 23]. Briefly, the left sciatic nerve was exposed, and 
three major divisions were clearly separated. Then, the 
tibial and sural nerves were tightly ligated and transected. 
Complete hemostasis was confirmed, and the wound was 
closed with muscle and skin sutures.
Changes in mechanical paw withdrawal threshold were 
measured before nerve injury (pre) and at 1, 4, and 7 days 
after nerve injury. Rats were habituated for 10 min to the 
testing cages, which consisted of metal mesh floors under 
plastic domes. Mechanical allodynia was measured by 
assessing thresholds for hind paw withdrawal upon stim-
ulation with an electrical von Frey filament (Ugo Basile, 
Varese, Italy). Mechanical forces were recorded with each 
withdrawal. Responses were measured seven times, and 
the means were calculated after the maximum and mini-
mum values were excluded (Additional file 1: Fig. S1).
Agent administration
On postoperative day 7, all rats were anesthetized with 
urethane (0.5 g/kg, i.p.) and α-chloralose (25 mg/kg). In 
addition, atropine (20  µg/kg, i.p.) was injected to avoid 
excessive mucus secretion in the trachea. The depth 
of anesthesia was determined by a lack of flexor mus-
cle response to hind-paw pinching. Then, the rats were 
mounted on the surgical stage. Skin incision was per-
formed on the right ventral aspect of the neck, and the 
common carotid artery and external carotid artery (ECA) 
Fig. 1 Schematic illustrating the experimental design. All rats underwent behavioral testing prior to nerve injury and at postoperative days (POD) 
1, 4, and 7. On each behavioral testing day, the mechanical threshold was assessed using an electronic von Frey filament. At POD 7, rats were 
prepared for MEMRI experiments to determine Mn-enhanced changes after evoked pain. MEMRI was performed following T2 scans, and regional 
Mn enhancement in the whole brain of experimental groups was compared
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were gently exposed. Polyethylene tubing (PE-10) was 
cannulated into the ECA.
Following catheter insertion, a 20% D-mannitol solu-
tion (35 ± 2 ℃, 5  ml/kg, Dai Han Pharm, Seoul, Korea) 
was infused to open the blood–brain barrier. To inves-
tigate pain-dependent signal changes in the whole 
brain following mTOR inhibition, nerve-injured rats 
were divided into three groups (Control, n = 8; Torin1, 
n = 8; and XL388, n = 8). Then, vehicle (0.06% DMSO in 
saline, 1 ml), Torin1 (400 nM in vehicle, 1 ml), or XL388 
(500 nM in vehicle, 1 ml) were infused in each group of 
rats. Following the application, 20  mM of manganese 
chloride  (MnCl2–4H2O, Sigma, St. Louis, MO, USA) was 
injected for MR imaging. All infusions were injected via 
the ECA (150 µl/min) using a syringe pump (22 Infusion 
Syringe Pump, Harvard Apparatus, Holliston, MA, USA). 
For noxious stimulation, electric stimulations (3  mA, 
2 Hz, 1 ms width; A385, WPI, Sarasota, FL, USA) were 
applied to the left hind paw during manganese chloride 
injection.
Magnetic resonance measurements
Magnetic resonance imaging (MRI) was performed using 
a 9.4-T horizontal Biospec small bore scanner (Bruker 
BioSpin, Ettlingen, Germany) with an 86-mm volume coil 
to transmit the radio frequency and a four-channel array 
coil to receive the signal. After tuning and shimming, T2 
multi-slice spin echo sequence images were acquired for 
positioning. T1W images were taken at the same posi-
tions. High-resolution anatomical images were obtained 
with a rapid acquisition with relaxation enhancement 
(RARE) protocol using the following parameters: effec-
tive TE = 28  ms, TR = 4750  ms, FOV = 32 × 32  mm, 
matrix = 192 × 192, and RARE factor = 8. Fifteen slices 
of T1W images were acquired using the RARE proto-
col with a shortened TR. The imaging parameters were 
RARE factor = 2, TE/TR = 8/412 ms, FOV = 32 × 32 mm, 
matrix = 192 × 192, and slice thickness = 1  mm. Res-
piration rates of animals were monitored during the 
experiments. Functional analysis was performed using 
ParaVision (Version 5.0, Bruker BioSpin). The whole 
brain was outlined on axial slices, and the mean sig-
nal was calculated. To quantify data from the series of 
T1W images and to measure  Mn2+ enhancement in 
separated brain regions, ROIs were set to entire brain 
regions covered in coronal images. ROIs at the insular 
cortex (IC), primary somatosensory cortex of the hind 
limb (S1HL), motor cortex 1/2 (M1/2), anterior cingulate 
cortex (ACC), and visual cortex 1/2 (V1/2) were manu-
ally drawn on each image. Signal magnitudes from each 
brain region were normalized to signal intensity in the 
temporalis muscle. Image analysis was performed using 
ParaVision (Bruker Biospin), MRVision (MRVision Co., 
Winchester, MA, US), and ImageJ software (National 
Institutes of Health, Bethesda, MD, US). Data are pre-
sented as a mean ± standard error of the mean (SEM). 
After MRI scans were taken, the rats were humanely 
killed with an overdose of urethane (1.5 mg/kg).
Statistical analysis
To quantify the data from T1W images and the measure-
ment of  Mn2+ enhancement in the brain, each ROI was 
set to the brain atlas covered in coronal images. Relative 
signal intensities were calculated and compared within 
groups. Data are presented as a mean ± SEM. One-way 
analysis of variance (ANOVA) followed by Dunnett’s 
post-hoc pairwise comparisons were used to identify 
mean differences in contrast at the ROIs. All statistical 
analyses were performed with Prism 5 software (Ver-
sion 8.03; GraphPad software Inc, San Diego, CA, US). 
P < 0.05 indicated a statistically significant difference.
Results
Analysis of Mn‑enhanced magnetic resonance signals
All of the acquired brain images exhibited regional 
heterogeneity in signal distribution typical of  MnCl2 
administration. The diffusion of  Mn2+ was found in the 
medial ventral region of the brain, hypothalamus, and 
specific pain-related structures. High-signal intensities 
were observed in the IC, S1HL, M1/2, and ACC (Fig. 2). 
V1/2 areas were also collected as a stimuli-independent 
ROI. Figure 2 illustrates ROIs from which average signal 
intensity was extracted (several ROIs extend over sev-
eral slices). In Fig.  3, the slice-dependent Mn-enhanced 
images of each group are compared (Fig. 3). During the 
comparison, high Mn-enhanced signals were observed in 
control (vehicle-infused) rats in all of the acquired slices. 
However, Torin1- and XL388-injected rats did not pre-
sent pain-related Mn-enhanced signals in the IC, S1HL, 
M1/2, or ACC regions.
Figure  4a shows the representative coronal (Fig.  4a 
upper left), sagittal (Fig.  4a right), and transverse 
(Fig.  4a left bottom) images of control rats (Fig.  4a). 
Across the brain regions, Mn-enhanced signals were 
significantly enhanced in the contralateral for nerve 
injury and peripheral stimulation. In the control 
group, the IC, S1HL, M1/2, and ACC showed higher 
mean signal intensities, compared to other groups. 
This indicated that large quantities of  Mn2+ ions were 
transported and accumulated in each region. Regional 
signal intensity comparisons are presented in Fig. 4b–f 
(Fig.  4b: IC, 4C: S1HL, 4D: M1/2, 4E: ACC, and 4F: 
V1/2). In contrast, signal intensities in Torin1- and 
XL388-infused rats were lower in the IC, S1HL, M1/2, 
and ACC (P < 0.05 for significant differences between 
drugs versus control group [ANOVA followed by 
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Dunnett’s post-hoc test]). Mean signal intensities in 
the IC, S1HL, M1/2, and ACC did not differ, however, 
between Torin1 and XL388 groups. The mean signal 
intensities of the V1/2 remained less-enhanced than 
those in other ROIs and were similar among the three 
groups, with no statistically significant differences 
(Fig. 4f ). The signal intensities of the ipsilateral primary 
somatosensory cortex of jaws (S1J) were higher in all 
groups. However, it was not related to the pain caused 
by the given hind paw stimulus, and was excluded from 
data analysis. All signal intensity values are presented 
in Table 1.
Comparison of Mn‑enhanced signal expression
To elucidate the differences between groups, we ana-
lyzed the integrated signal values of ROIs, and the IC 
and M1/2 regions were divided into rostral-caudal 
parts and analyzed. The comparison of regional signal 
intensities between groups is presented in Fig.  5. Stim-
ulus-dependent Mn-enhanced signal intensities were 
Fig. 2 Representative images and colors of ROIs used to calculate average signal intensities. The selected ROIs are shown overlaid on T1 scans in 
coronal slices (anterior to posterior, respectively). M1/2: motor cortex 1/2, IC: insula, S1HL: primary somatosensory cortex hind limb region, ACC: 
anterior cingulate cortex, V1/2: visual cortex 1/2. Distances indicated are measurements from bregma according to the Paxinos and Watson rat brain 
atlas [48]
Fig. 3 Comparison of T1-weighted MEMRI following  MnCl2 injection in each group. MR imaging was performed for separate groups: control 
(vehicle), Torin1-, and XL388-infused with electrical stimulation in the hind paw. In control rats, Mn-enhanced signals were observed in the right 
hemisphere of the brain. However, Torin1- or XL388-infused rats did not show region-specific increases in Mn-signals in the brain. Images were 
obtained from bregma 3 mm to − 3 mm MRI scan
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significantly reduced after Torin1 and XL388 infusion, 
and Mn-enhanced signals after hind paw stimulation 
in the IC appeared higher in the rostral planes (Fig.  5a, 
bregma 2 and 1 mm) than in the caudal planes (Fig. 5b, 
bregma − 1 and − 2 mm) of the IC. In the S1HL, which 
directly received painful nociception signals after stimuli, 
we observed increased signal values in the whole plane 
in the control group. However, significant reductions 
were observed in the Torin1- or XL388-infused rats 
(Fig. 5c). In the M1/2 rostral-caudal comparison, Torin1- 
and XL388-infused rats showed regional specific Mn-
enhancement in the M1/2 area, compared to control rats 
(Fig. 5d and e). At the caudal part of the M1/2 (Fig. 5e, 
bregma − 1, − 2, and − 3 mm), there was no significant 
difference between groups. However, for the rostral part 
of M1/2 (Fig. 5d, bregma 2 and 1 mm), data from Torin1- 
or XL388-injected groups showed significantly lower 
values (Fig. 5d, ANOVA followed by Dunnett’s post-hoc 
test). In addition, in the comparison of signal intensities 
in the ACC, Torin1- or XL388-treated groups showed 
significantly reduced signal enhancement in the rostral 
part (Fig. 4f, bregma 2 and 1 mm). However, the V1/2 sig-
nal intensities in pain-independent brain regions showed 
no difference in any group.
Stimulus‑induced signal intensities in ROIs
In order to quantify the stimulus-dependent signal inten-
sity changes, signal intensities at ROIs were compared 
to the signal intensities of the V1/2 regions of the same 
animals (Fig. 6). In signal intensity comparisons between 
the rostral area of the IC and the caudal area of the IC, 
the rostral area of the IC showed more enhanced sig-
nal activities when painful stimuli were given to the 
hind paw, compared to the caudal area of the IC. This 
Fig. 4 Mn-enhanced rat brain and regional signal intensity changes. a Following administration of  MnCl2, there was a heterogeneous signal 
distribution, as shown in the coronal (left upper), horizontal (left bottom), and sagittal planes (right) of the rat brain. b–f Line graphs depict the 
means and standard errors for Mn-enhanced signal intensity in each brain region of the control (blue lines), Torin1 (red lines), and XL388 (black lines) 
rats. Five regions of Mn-enhanced signal intensity in MR images were analyzed and compared. Signal intensities in Torin1- and XL388-injected rats 
were lower than those in control (vehicle injected) rats. *P < 0.05; **P < 0.01. Data are presented as a mean ± SEM
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signal enhancement was more explicit when compared 
to the V1/2 (Fig.  6a; rostral-IC 2.04 ± 0.28, caudal-
IC 1.42 ± 0.19, and V1/2 1.47 ± 0.11). In addition, the 
S1HL directly reflected hind paw stimulation, and signal 
differences with V1/2 were greater than those in other 
regions (Fig. 6b; S1HL 2.59 ± 0.25, and V1/2 1.47 ± 0.11). 
In comparison of mean signal enhancement in the M1/2 
region, the rostral part of the M1/2 region showed more 
Table 1 Mean signal intensities of ROIs
Comparison of Control vs. Torin1 or XL388 (*P < 0.05 and **P < 0.01)
Region Group Distance from bregma
3 mm 2 mm 1 mm 0 − 1 mm − 2 mm − 3 mm − 5 mm − 6 mm
IC Control 2.44 ± 0.47 1.64 ± 0.17 1.49 ± 0.29 1.54 ± 0.32 1.31 ± 0.18
Torin1 1.25 ± 0.13** 1.05 ± 0.12** 1.04 ± 0.08 1.12 ± 0.12 1.04 ± 0.08
XL388 1.27 ± 0.17** 1.03 ± 0.09** 0.98 ± 0.12 0.91 ± 0.04 0.83 ± 0.06
S1HL Control 2.89 ± 0.45 2.68 ± 0.49 2.20 ± 0.25
Torin1 1.71 ± 0.16** 1.78 ± 0.21** 1.49 ± 0.13**
XL388 1.51 ± 0.14** 1.45 ± 0.14** 1.32 ± 0.12**
M1/2 Control 2.53 ± 10.37 2.85 ± 9.35 2.85 ± 0.41 2.34 ± 0.36 2.08 ± 0.39 1.68 ± 0.13 1.72 ± 0.18
Torin1 1.81 ± 0.19 1.86 ± 0.21** 1.72 ± 0.21** 1.66 ± 0.19 1.69 ± 0.23 1.47 ± 0.16 1.50 ± 0.20
XL388 1.92 ± 0.16 1.95 ± 0.28* 1.82 ± 0.18** 1.69 ± 0.16 1.46 ± 0.13 1.39 ± 0.15 1.28 ± 0.10
ACC Control 2.31 ± 0.23 1.96 ± 0.19 1.89 ± 0.36 2.11 ± 0.46
Torin1 1.93 ± 0.48** 1.93 ± 0.48** 1.91 ± 0.48 1.92 ± 0.47
XL388 1.30 ± 0.12** 1.26 ± 0.10** 1.23 ± 0.08 1.20 ± 0.08
V1/2 Control 1.49 ± 0.15 1.46 ± 0.15
Torin1 1.38 ± 0.07 1.42 ± 0.10
XL388 1.33 ± 0.14 1.43 ± 0.17
Fig. 5 Comparison of  Mn2+ enhancement in the ROIs after noxious stimulation. The IC regions were analyzed by rostral-caudal analysis (a, b). 
S1HL regions showed increased signals in all groups. However, Torin1-, or XL388-treated rats showed reduced signal intensities (c). Torin1- and 
XL388-treated rats showed significantly reduced signal intensities at the rostral M1/2 area (d, e). In the comparison of ACC, Torin1- and 
XL388-treated groups showed a significant reduction in signal enhancement (f). However, V1/2 signals did not show any difference within 
groups (g). Each group is presented by different colors (control: blue, Torin1: red, and XL388: white). *P < 0.05; **P < 0.01. Data are presented as a 
mean ± SEM
Page 7 of 10Cha et al. Mol Brain          (2020) 13:158  
enhanced activities, compared to the caudal part of 
M1/2 region (Rostral-M1/2 2.20 ± 0.22 vs. Caudal-M1/2 
1.48 ± 0.14). However, the difference was not significant 
in comparison with the V1/2 region. In addition, the 
ACC also showed no significant difference compared to 
the V1/2 signal intensities (Fig. 6d ACC 2.07 ± 0.17).
Discussion
The purpose of this study was to evaluate the usefulness 
of MEMRI in chronic pain research using whole brain 
analysis, as well as to measure changes in brain activities 
after drug administration in a chronic pain model. In this 
study, we demonstrated cortico-cortical neural excitation 
of several ROIs under chronic neuropathy using MEMRI, 
as well as changes in Mn-enhanced signals of the pain-
related cortex area after direct infusion of mTOR inhibi-
tors in the brain. Until now, the effects of mTOR inhibitor 
using animal MRI have not been studied. Several stud-
ies have used the MEMRI method to assess pain in the 
central nervous system or to observe changes in pain 
through analgesic use [3, 10, 24]. However, the MEMRI 
method has several difficulties in observing the effects 
of pain reduction or changes in neuronal activities. In 
order to abbreviate these problems, we tried to observe 
dynamic changes in the brain using ECA injection with 
 MnCl2.
The meaning of Mn2+ enhancement in ROIs
MEMRI has advantages of a fast influx and enhance-
ments of  Mn2+ in the tissues [24]. In addition, the cumu-
lative  Mn2+ pattern is retained for several days, and it 
also provides a good opportunity to observe activated 
brain changes upon stimulation when viewed through 
T1-weighted MRI [5]. Quantitative evaluation of contrast 
enhancement showed that  MnCl2 injection via ECA may 
be the best way to show hind paw stimulation-induced 
pain in rats, with the best signal-to-noise ratio [2]. The 
Mn-injection method through ECA could observe the 
signal changes only on the ipsilateral side, which is 
related to blood circulation in the brain [25]. In order to 
observe whole brain activation with MEMRI, Mn-injec-
tion through subarachnoid or direct injection into the 
brain regions were also considered. Nevertheless, Mn-
injection through the ECA for MEMRI was considered 
to better facilitate the observation of specific structures 
and activity, rather than mere signal enhancement by 
Mn-diffusion.
Reliable brain activities were observed using the 
MEMRI method in the control, Torin1-, and XL388-
infused groups.  Mn2+ enhancement of individual slices 
was measured and analyzed in the rostral and cau-
dal regions. Integrated signal analysis of the IC showed 
higher activated signals in the rostral region than in the 
caudal region of control animals. These results were con-
sistent with previous findings that the rostral part of the 
IC is more involved in pain processing [26, 27]. A previ-
ous anatomical study [26] revealed that the rostral part of 
the IC receives considerable input from the centrolateral 
and mediodorsal thalamus, which showed strong activity 
in response to noxious stimulus in MEMRI results. The 
functional characteristics of the caudal part of IC were 
clearly distinct from those of the rostral part of IC, which 
has received attention for its role in nociceptive process-
ing [28]. The rostral part of IC directly accepts the pain 
caused by stimulation, while the caudal part of IC may 
function pathologically with persistent maintenance of 
mechanical allodynia [29]. In this study, rats infused with 
Torin1 or XL388 showed not only a reduction of signals 
in the rostral part of IC, but also a reduction of signals 
in the caudal part of IC. In addition to the IC, other cor-
tical target regions, such as the S1HL and ACC, have 
been investigated to evaluate the pain inhibition effects 
after medication. In the S1HL, which directly reflects 
noxious stimulation, subcutaneous electrical stimulation 
Fig. 6 Analysis of stimulation-dependent ROIs in control rats. Relative manganese-enhanced MRI-T1-contrast for the investigated insular (rostral 
and caudal), S1HL, M1/2 (rostral and caudal), and ACC regions of the brain in control (blue or red columns), compared to visual cortex (white 
columns). Each P value indicates a significant difference between groups. Data are presented as a mean ± SEM
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in the hind paw could activate Aβ fibers from cutane-
ous receptors [30]. Evoked pain sensation was reflected 
in the S1HL. In addition, the ACC was consistently acti-
vated in nociception in human and animal studies [31]. 
Previous research has indicated that the neuronal plastic-
ity in ACC is highly correlated with the development of 
chronic pain [32, 33]. Although the ACC has been shown 
to be associated with different aspects of pain, precise 
functional mapping of these aspects still remains largely 
unknown.
Interestingly, we observed enhanced signals in the 
M1/2 region upon noxious hind paw stimulation. 
Although M1/2 is not a part of the pain matrix, it is 
known that the M1/2 has wide connections to some of 
the sensory relay nuclei in the thalamus, as well as to 
efferent and afferent fibers in the spinal cord, that are 
responsible for the transmission of painful stimuli and 
modulation of the motor response to noxious contact. 
Previous investigators have indicated that the motor cor-
tex in rats and mice partially overlaps the S1 to form a 
“sensorimotor amalgam” that largely involves representa-
tions of the hind limb [34–36]. Despite this knowledge, it 
is difficult to explain how noxious stimuli in the hind paw 
activate the M1/2. Further research is required to explain 
the role of the M1/2 in pain perception.
How can mTOR inhibition reduce brain activities 
in response to chronic pain?
Modulation of chronic pain through mTOR inhibition is 
a newly studied target for chronic pain control [16, 37]. 
Previous studies have observed changes in chronic pain 
through the inhibition of mTOR signaling in the spi-
nal cord [38–41], and recent studies have demonstrated 
effective modulation of chronic pain by direct mTOR 
signaling control in the brain [16, 32, 42], The activa-
tion of mTOR regulates protein synthesis by phospho-
rylating downstream effectors, which influence a wide 
range of physiological and pathological states, includ-
ing neuropathic, inflammatory, and cancer-related pain 
[16–18]. The mTOR inhibitors Torin1 and XL388 used 
in this study are ATP-competitive inhibitors that sup-
press the phosphorylation of downstream effectors to 
regulate mRNA translation and protein synthesis [43]. 
Our previous research revealed how Torin1/XL388 can 
change chronic pain after nerve injury [44, 45]. In these 
studies, Torin1 or XL388 was microinjected into the 
brain of nerve-injured animals and behavioral changes 
were assessed. The results indicated that the administra-
tion of Torin1 or XL388 significantly increased mechani-
cal thresholds and reduced mechanical allodynia. These 
results strongly suggest that Torin1 and XL388 may 
attenuate neuropathic pain via inhibition of mTOR in 
the brain. Remarkably, the Torin1- and XL388-infused 
rats showed reduced Mn-enhanced signals in the corti-
cal area, including the IC, S1HL, M1/2, and ACC. These 
results demonstrate that mTOR inhibition may have 
an effect on activation of other brain regions, as well as 
pain reduction through the inhibition of phosphoryla-
tion by mTOR control [13, 32, 38]. The maintenance of 
long-term potentiation (LTP) is dependent on protein 
synthesis, and mTOR signaling is involved in the local 
protein synthesis required for the maintenance of LTP. 
In the process of pain-related neural plasticity, mTOR 
kinase is one of the key factors related to protein syn-
thesis. Also, increases in mTOR following nerve injury 
has been shown to increase phosphorylation, indicat-
ing that the protein synthesis involved in neural plastic-
ity causing neuropathic pain is increased. Our another 
previous research has reported that the expressions of 
mTOR-related translation factors, such as 4E-BP1 and 
p70S6K, are increased under chronic pain conditions 
[16]. In addition, several studies have confirmed activa-
tion of PKCα, which follows mTOR phosphorylation [46, 
47]. PKCα is known to play a critical role in cytoskeleton 
rearrangement induced by mTOR. Moreover, down-reg-
ulation of the PKCα generates an abnormal cell shape or 
excessive actin cytoskeleton and alters neurons by rear-
ranging their configuration, volume, or length. Thus, we 
assume that the reduced signal intensities observed in the 
Torin1- and XL388-treatment groups may be attributable 
to the relief of neuropathic pain due to inhibition of pro-
tein synthesis and cytoskeleton rearrangement associated 
with mTOR.
In our results, there were no differences in signal 
enhancement ratios between experimental groups in the 
V1/2 region. These results indicate that the inhibitory 
effect of mTOR signaling is not significantly different in 
response to similar visual cues. Recent studies have sug-
gested that mTOR signaling may be involved in the initia-
tion of pain perception [15, 19], which could effectively 
reduce chronic pain through inhibition of mTOR. How-
ever, the amount of research on how pain is controlled 
due to regulation of mTOR is still insufficient. A better 
understanding of these signaling pathways would provide 
great insights into the underlying mechanisms and lead 
to more refined therapeutic approaches.
In conclusion, the activity-dependent Mn-enhanced 
magnetic resonance signals after mTOR inhibition 
reported herein indicated that pharmaceutical inhibition 
of mTOR signaling in the brain could reduce abnormal 
cortex activities after chronic neuropathic pain. Further-
more, rostral-caudal analysis revealed that the rostral 
regions of IC and M1/2 are more related to pain percep-
tions than caudal regions. Nevertheless, MRI studies with 
manganese ions have many challenges, due to the restric-
tive pass capability of the blood–brain barrier, in addition 
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to difficulties in controlling the accumulation of manga-
nese in tissues and physiological changes in the body. The 
development of various studies using improved MR tech-
niques, real-time optical imaging with voltage-sensitive 
dye, and brain slice recordings may help contribute to 
future studies of neural mechanisms and help to advance 
knowledge of cerebral activation in chronic pain.
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